Cover Image

Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab

Introduction: The advent of biotechnological drugs has significantly changed the management of atopic dermatitis (AD) and the approach to the moderate-to-severe form of this chronic relapsing disease. Objectives: The aim of our review is to summarize the current literature on anti-interleukin (IL)-1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Annunziata Dattola (Author), Martina Tolone (Author), Emanuele Amore (Author), Luigi Bennardo (Author), Simone Amato (Author), Teresa Grieco (Author), Antonio Giovanni Richetta (Author), Giovanni Pellacani (Author), Nevena Skroza (Author), Steven Paul Nisticò (Author)
Format:	Book
Published:	Mattioli1885, 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro
by: Maxim A.X. Tollenaere, et al.
Published: (2021)

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals
by: Giovanni Paolino, et al.
Published: (2024)

Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis
by: Galina Balakirski, et al.
Published: (2023)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024)

Real‐life case‐series experience with tralokinumab in patients with severe atopic dermatitis
by: Francesca Caroppo, et al.
Published: (2024)

Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience
by: Silvia Ferrucci, et al.
Published: (2023)

Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis and Asthma who Developed Hypereosinophilia: A Case Report
by: Ilaria Trave, et al.
Published: (2024)

Therapeutic Potential of Tralokinumab in the Treatment of Atopic Dermatitis: A Review on the Emerging Clinical Data
by: Kelly KA, et al.
Published: (2022)

Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis
by: L. Mastorino, et al.
Published: (2023)

Real-World Experience with Tralokinumab in a Patient with Recalcitrant Atopic Dermatitis: A Case Report
by: Moennig E, et al.
Published: (2022)

Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series
by: Patrícia Amoedo, et al.
Published: (2024)

Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
by: Yuliya Lytvyn, et al.
Published: (2023)

Rapid response on facial psoriasis to bimekizumab: case series
by: Nicoletta Bernardini, et al.
Published: (2024)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024)

Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
by: Kaidi Zhao, et al.
Published: (2024)

Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
by: Luigi Gargiulo, et al.
Published: (2023)

Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis,
by: Camilla Chello, et al.
Published: (2021)

The role of interleukin-1ß and interleukin-33 in atopic dermatitis
by: Rania M. Abdel Hay, et al.
Published: (2013)

comment: The role of interleukin-1ß and interleukin-33 in atopic dermatitis
by: Miloš Jeseňák
Published: (2013)

Severe atopic dermatitis treated with anti-interleukin 4Rα reduces the psychological burden in patients with and without alexithymia
by: Vincenzo Patella, MD, et al.
Published: (2024)

Profile of Serum Interleukin-31 Levels in Atopic Dermatitis
by: Dewi Kusumawati, et al.
Published: (2017)

Dual Interleukin-4/Interleukin-13 Blocker-induced Arthralgia Treated Successfully with Upadacitinib in a Patient with Atopic Dermatitis
by: Takayuki Tanji, et al.
Published: (2023)

Atopic Dermatitis: Epidemiology and Clinical Phenotypes
by: Annunziata Raimondo, et al.
Published: (2021)

Allergen-specific immunoglobulin E and interleukin 33 in atopic dermatitis
by: Małgorzata Bernacka, et al.
Published: (2019)

Atopic Dermatitis Onset in a Melanoma Patient Under Pembrolizumab Therapy: A Case of Successful Treatment with Dupilumab
by: Ersilia Tolino, et al.
Published: (2024)

Association between vitamin D receptor polymorphisms, tight junction proteins and clinical features of adult patients with atopic dermatitis
by: Teresa Grieco, et al.
Published: (2024)

Inhibition of Interleukin-4 Signalling in the Treatment of Atopic Dermatitis and Allergic Asthma
by: Neena Philips, et al.
Published: (2017)

Changes in induced regulatory T cells by interleukin 35 during atopic dermatitis
by: Soheil Tavakolpour
Published: (2016)

Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study)
by: Diego Orsini, et al.
Published: (2024)

Oxidative Stress and Atopic Dermatitis
by: Lucrezia Bertino, et al.
Published: (2020)

Nd:YAG laser in association with pulsed dye laser for the treatment of PHACES syndrome
by: Francesca Negosanti, et al.
Published: (2021)

Neck Rejuvenation With a New Infrared Emission
by: Olga Mastrangelo, et al.
Published: (2022)

Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date
by: Rega F, et al.
Published: (2024)

Atopic Dermatitis in the Elderly Population
by: Martina Maurelli, et al.
Published: (2023)

In vitro interleukin 4 and interferon-gamma production by mononuclear cells from atopic dermatitis patients
by: Serge Well, et al.
Published: (1993)

Moisturizing Nanoemulgel of Turmeric (Curcuma longa) Rhizome Extract Ameliorates Atopic Dermatitis-like Skin Lesions in Mice Model through Thymic Stromal Lymphopoietin, Interleukin-13, and Interleukin-17
by: Nyoman Suryawati, et al.
Published: (2022)

Selective IL-13 inhibitors for the treatment of atopic dermatitis
by: Francisca Gonçalves, et al.
Published: (2021)

Relationship between serum 25-hydroxyvitamin D and interleukin-31 levels, and the severity of atopic dermatitis in children
by: Bo Ram Cheon, et al.
Published: (2015)

Intrinsic Atopic Dermatitis and Extrinsic Atopic Dermatitis: Similarities and Differences
by: Liu L, et al.
Published: (2022)

ATOPIC DERMATITIS
by: L.S. Namazova, et al.
Published: (2006)